| Periodontal disease: a risk factor for diabetes and cardiovascular disease D Liccardo, A Cannavo, G Spagnuolo, N Ferrara, A Cittadini, C Rengo, ... International journal of molecular sciences 20 (6), 1414, 2019 | 432 | 2019 |
| Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy A Cannavo, D Liccardo, WJ Koch Frontiers in physiology 4, 65601, 2013 | 126 | 2013 |
| Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms A Bathgate-Siryk, S Dabul, K Pandya, K Walklett, G Rengo, A Cannavo, ... Hypertension 63 (2), 404-412, 2014 | 114 | 2014 |
| microRNA in cardiovascular aging and age-related cardiovascular diseases C de Lucia, K Komici, G Borghetti, GD Femminella, L Bencivenga, ... Frontiers in medicine 4, 74, 2017 | 109 | 2017 |
| Targeting β3-adrenergic receptors in the heart: selective agonism and β-blockade A Cannavo, WJ Koch Journal of cardiovascular pharmacology 69 (2), 71-78, 2017 | 100 | 2017 |
| Sphingosine kinases and sphingosine 1-phosphate receptors: signaling and actions in the cardiovascular system A Cannavo, D Liccardo, K Komici, G Corbi, C De Lucia, GD Femminella, ... Frontiers in pharmacology 8, 280098, 2017 | 97 | 2017 |
| Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure V Parisi, G Rengo, P Perrone-Filardi, G Pagano, GD Femminella, ... Circulation research 118 (8), 1244-1253, 2016 | 94 | 2016 |
| GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility NC Salazar, X Vallejos, A Siryk, G Rengo, A Cannavo, D Liccardo, ... Cell Communication and Signaling 11, 1-10, 2013 | 91 | 2013 |
| β1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and … A Cannavo, G Rengo, D Liccardo, G Pagano, C Zincarelli, MC De Angelis, ... Circulation 128 (15), 1612-1622, 2013 | 83 | 2013 |
| Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure G Rengo, A Lymperopoulos, C Zincarelli, GD Femminella, D Liccardo, ... British Journal of Pharmacology 166 (8), 2430-2440, 2012 | 83 | 2012 |
| Potential bidirectional relationship between periodontitis and Alzheimer’s disease D Liccardo, F Marzano, F Carraturo, M Guida, GD Femminella, ... Frontiers in physiology 11, 683, 2020 | 79 | 2020 |
| Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure G Rengo, A Cannavo, D Liccardo, C Zincarelli, C De Lucia, G Pagano, ... Circulation: Heart Failure 6 (6), 1259-1267, 2013 | 71 | 2013 |
| Structure-based design, synthesis, and biological evaluation of highly selective and potent G protein-coupled receptor kinase 2 inhibitors HV Waldschmidt, KT Homan, O Cruz-Rodríguez, MC Cato, ... Journal of medicinal chemistry 59 (8), 3793-3807, 2016 | 68 | 2016 |
| Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure C Perrino, GG Schiattarella, A Sannino, G Pironti, MP Petretta, A Cannavo, ... Journal of the American Heart Association 2 (3), e000086, 2013 | 66 | 2013 |
| Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases A Cannavo, D Liccardo, A Eguchi, KJ Elliott, CJ Traynham, J Ibetti, ... Nature communications 7 (1), 10877, 2016 | 65 | 2016 |
| Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight … DM Trappanese, Y Liu, RC McCormick, A Cannavo, G Nanayakkara, ... Basic research in cardiology 110, 1-14, 2015 | 64 | 2015 |
| EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy G Esposito, C Perrino, A Cannavo, GG Schiattarella, F Borgia, A Sannino, ... Basic research in cardiology 106, 577-589, 2011 | 64 | 2011 |
| GRK2 as a therapeutic target for heart failure A Cannavo, K Komici, L Bencivenga, ML D’amico, G Gambino, D Liccardo, ... Expert Opinion on Therapeutic Targets 22 (1), 75-83, 2018 | 62 | 2018 |
| Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology A Cannavo, L Bencivenga, D Liccardo, A Elia, F Marzano, G Gambino, ... Oxidative medicine and cellular longevity 2018, 2018 | 61 | 2018 |
| GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels PY Sato, JK Chuprun, J Ibetti, A Cannavo, K Drosatos, JW Elrod, WJ Koch Journal of molecular and cellular cardiology 89, 360-364, 2015 | 61 | 2015 |
